Peak Bio (PKBO) Stock

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

15 March 2021

Indexes:

Not included

Description:

PKBO (Peak Bio) is a biotechnology company focused on developing innovative therapies for serious diseases. They aim to improve patient outcomes through advanced research and technology, targeting conditions like cancer and autoimmune disorders. Their mission is to create effective treatments that enhance the quality of life for patients.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Nov 21, 2022

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

04 Nov '22 Ladenburg Thalmann
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

FAQ

  • What is the primary business of Peak Bio?
  • What is the ticker symbol for Peak Bio?
  • Does Peak Bio pay dividends?
  • What sector is Peak Bio in?
  • What industry is Peak Bio in?
  • What country is Peak Bio based in?
  • When did Peak Bio go public?
  • Is Peak Bio in the S&P 500?
  • Is Peak Bio in the NASDAQ 100?
  • Is Peak Bio in the Dow Jones?
  • When was Peak Bio's last earnings report?
  • When does Peak Bio report earnings?
  • Should I buy Peak Bio stock now?

What is the primary business of Peak Bio?

PKBO (Peak Bio) is a biotechnology company focused on developing innovative therapies for serious diseases. They aim to improve patient outcomes through advanced research and technology, targeting conditions like cancer and autoimmune disorders. Their mission is to create effective treatments that enhance the quality of life for patients.

What is the ticker symbol for Peak Bio?

The ticker symbol for Peak Bio is NASDAQ:PKBO

Does Peak Bio pay dividends?

No, Peak Bio does not pay dividends

What sector is Peak Bio in?

Peak Bio is in the Healthcare sector

What industry is Peak Bio in?

Peak Bio is in the Biotechnology industry

What country is Peak Bio based in?

Peak Bio is headquartered in United States

When did Peak Bio go public?

Peak Bio's initial public offering (IPO) was on 15 March 2021

Is Peak Bio in the S&P 500?

No, Peak Bio is not included in the S&P 500 index

Is Peak Bio in the NASDAQ 100?

No, Peak Bio is not included in the NASDAQ 100 index

Is Peak Bio in the Dow Jones?

No, Peak Bio is not included in the Dow Jones index

When was Peak Bio's last earnings report?

Peak Bio's most recent earnings report was on 21 November 2022

When does Peak Bio report earnings?

The date for Peak Bio's next earnings report has not been announced yet

Should I buy Peak Bio stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions